Testosterone 100mg Anastrozole 4mg recall — Class II (D-0331-2026) · pharmaranks
Class IIOngoing
Testosterone 100mg Anastrozole 4mg recall
FDA recall D-0331-2026 · initiated Jan 26, 2026
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of Foreign substance - potential presence of metal particulate matter
Details
Product
Testosterone 100mg Anastrozole 4mg , 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-32
Recalling company
F.H. INVESTMENTS, Inc. (dba Asteria Health)
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
Nationwide in the USA
Initiated
Jan 26, 2026
FDA report date
Feb 18, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.